COVID-19 Impact on Abiomed Inc.’s Revenue and Operations (Medical Devices)
Abiomed Inc. is a medical technology company which designs, develops, manufactures and markets a specific product range of Mechanical Circulatory Support Devices as a leading brand all over the world. Abiomed specializes in heart pumps, which are indicated for cardiogenic shock, including AMI, right heart failure, cardiomyopathy and myocarditis, or for patients with advanced heart failure undergoing PCI. The report, COVID-19 Impact on Abiomed Inc.’s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Abiomed Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
Deep dive analysis into how Abiomed Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
- The spread of the disease has negatively impacted Abiomed’s sales.
- The rising number of cases in the US, which is Abiomed’s main market, will continue to worsen outlook for the company.
The report provides a comprehensive analysis of the impact of COVID-19 on Abiomed Inc. -
- It provides insights on Abiomed Inc.’s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
Reasons To Buy
- An overview of how Abiomed Inc. will be affected by the COVID-19 pandemic.